Lu Daopei Hematology Hospital
Hematology oncology treatment in China typically costs from $2,200 to $275,000. Final expenses depend on the cancer stage, the use of domestic versus imported medications, and the specific cell therapy protocols required. Patients often find 50–85% savings compared to the United States for advanced blood cancer treatments.
Typical Hematology Oncology Costs in China
Major hematology centers are concentrated in Beijing, Shanghai, and Guangzhou. Costs in these Tier-1 cities are generally higher than in regional facilities due to advanced technology. You should consult with a specialist to get accurate pricing for your specific medical case.
| China | Turkey | Austria | |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
| Lymphoma chemotherapy | from $18,500 | from $3,000 | from $8,000 |
| Chemotherapy | from $3,800 | from $2,430 | from $2,500 |
| CAR T-cell therapy | from $165,000 | from $150,000 | from $350,000 |
| Bone marrow transplantation | from $55,000 | from $36,000 | from $140,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hematology Oncology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hematology Oncology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hematology Oncology treatment journey.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Written by Anna Leonova
Written by Anna Leonova
Written by Halina Shubala